From Name

From Email

To Name

To Email

Message

COVID Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker Says

from HealthDay News

COVID Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker Says HealthDay News The maker of remdesivir, the first drug that showed promise in treating coronavirus infections, will charge U.S. hospitals $3,120 for a patient with private insurance, the drug company announced. Because of how the U.S. health care system is designed and the discounts that government health care programs like the VA and Medicaid will expect, the price for private insurance companies will be $520 per vial, Gilead Sciences explained in a letter. READ MORE

more